Merck & Company Inc's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Other-Long-Term-Assets" stands at 18.33 Billion United States Dollars as of 09/30/2025, the highest value at least since 03/31/2011, the period currently displayed.
As of the end of Merck & Company Inc's third quarter, the item "Other Long Term Assets" stands at 18.33 Billion USD. This represents an increase of 3.79 percent compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 26.93 percent compared to the value the year prior.
The 1 year change in percent is 26.93.
The 3 year change in percent is 91.29.
The 5 year change in percent is 128.96.
The 10 year change in percent is 226.33.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Other Long Term Assets | 905,699,262,464.00 |
![]() | Johnson & Johnson - Other Long Term Assets | 486,508,953,600.00 |
![]() | AbbVie Inc - Other Long Term Assets | 399,570,305,024.00 |
![]() | Roche Holding AG - Other Long Term Assets | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Other Long Term Assets | 280,205,508,085.11 |